Scpharmaceuticals Performance

SCPHDelisted Stock  USD 5.67  0.01  0.18%   
The entity has a beta of 0.12, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Scpharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Scpharmaceuticals is expected to be smaller as well. Scpharmaceuticals right now has a risk of 0.0%. Please validate Scpharmaceuticals maximum drawdown, accumulation distribution, relative strength index, as well as the relationship between the semi variance and day typical price , to decide if Scpharmaceuticals will be following its existing price patterns.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Scpharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Scpharmaceuticals is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
Begin Period Cash Flow46.8 M
Total Cashflows From Investing Activities29.3 M
  

Scpharmaceuticals Relative Risk vs. Return Landscape

If you would invest  567.00  in Scpharmaceuticals on October 28, 2025 and sell it today you would earn a total of  0.00  from holding Scpharmaceuticals or generate 0.0% return on investment over 90 days. Scpharmaceuticals is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Scpharmaceuticals, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

Scpharmaceuticals Target Price Odds to finish over Current Price

The tendency of Scpharmaceuticals Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 5.67 90 days 5.67 
about 18.26
Based on a normal probability distribution, the odds of Scpharmaceuticals to move above the current price in 90 days from now is about 18.26 (This Scpharmaceuticals probability density function shows the probability of Scpharmaceuticals Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Scpharmaceuticals has a beta of 0.12. This usually implies as returns on the market go up, Scpharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Scpharmaceuticals will be expected to be much smaller as well. Additionally Scpharmaceuticals has an alpha of 0.5862, implying that it can generate a 0.59 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Scpharmaceuticals Price Density   
       Price  

Predictive Modules for Scpharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Scpharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
5.675.675.67
Details
Intrinsic
Valuation
LowRealHigh
4.584.586.24
Details
Naive
Forecast
LowNextHigh
5.985.985.98
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
5.575.635.69
Details

Scpharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Scpharmaceuticals is not an exception. The market had few large corrections towards the Scpharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Scpharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Scpharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.59
β
Beta against Dow Jones0.12
σ
Overall volatility
0.53
Ir
Information ratio 0.15

Scpharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Scpharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Scpharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Scpharmaceuticals is not yet fully synchronised with the market data
Scpharmaceuticals has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 36.33 M. Net Loss for the year was (85.15 M) with profit before overhead, payroll, taxes, and interest of 34.21 M.
Scpharmaceuticals currently holds about 55.85 M in cash with (70.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.04.
Over 80.0% of the company shares are owned by institutional investors

Scpharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Scpharmaceuticals Stock often depends not only on the future outlook of the current and potential Scpharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Scpharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding44.5 M
Cash And Short Term Investments75.7 M

Scpharmaceuticals Fundamentals Growth

Scpharmaceuticals Stock prices reflect investors' perceptions of the future prospects and financial health of Scpharmaceuticals, and Scpharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Scpharmaceuticals Stock performance.

About Scpharmaceuticals Performance

By evaluating Scpharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Scpharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Scpharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Scpharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts. SC Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.

Things to note about Scpharmaceuticals performance evaluation

Checking the ongoing alerts about Scpharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Scpharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Scpharmaceuticals is not yet fully synchronised with the market data
Scpharmaceuticals has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 36.33 M. Net Loss for the year was (85.15 M) with profit before overhead, payroll, taxes, and interest of 34.21 M.
Scpharmaceuticals currently holds about 55.85 M in cash with (70.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.04.
Over 80.0% of the company shares are owned by institutional investors
Evaluating Scpharmaceuticals' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Scpharmaceuticals' stock performance include:
  • Analyzing Scpharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Scpharmaceuticals' stock is overvalued or undervalued compared to its peers.
  • Examining Scpharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Scpharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Scpharmaceuticals' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Scpharmaceuticals' stock. These opinions can provide insight into Scpharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Scpharmaceuticals' stock performance is not an exact science, and many factors can impact Scpharmaceuticals' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Scpharmaceuticals Stock

If you are still planning to invest in Scpharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Scpharmaceuticals' history and understand the potential risks before investing.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk